CNBC Fast Money · · 48 min

Nvidia Sinks to Cap Worst Week Since 2008 and Nasdaq Goes Negative For the Year

With Carter Braxton Worth, Ed Zitron, Jared Holz

ChorusBring the market's conversation to your AI. Learn more

Summary

CNBC Fast Money recapped a sharp week in which Nvidia sank to its worst week since 2008 and the Nasdaq turned negative for the year. Ed Zitron was the most bearish voice, arguing that Nvidia's dependence on circular AI financing, an SEC probe, Oracle's fragile OpenAI data-center funding, OpenAI's ability to fund itself, and the neoclouds' rate sensitivity all point to further declines, and he cast the Anthropic IPO as a liquidity event for retail. Tim Seymour and Karen Finerman saw Nvidia's drop as overdone on a roughly seven-times forward multiple, while Carter Worth and Steve Grasso expected a holiday-week bounce, with Grasso also flagging Fed policy-error risk, trade-truce deadlines and copper and gold moves. Panelists also weighed bank exposure to AI financing, bearish crypto sentiment after the stalled Clarity Act, and healthcare valuations and pharma M&A, with Seymour favouring cash-generative mega-caps such as Alphabet, Amazon, Microsoft and Meta.

Key takeaways

  • Tim Seymour (uncertain on NVIDIA): Nvidia trades near 7x 2028 earnings; the selloff is retail capitulation, not a multiple problem.
  • Karen Finerman (bullish on NVIDIA): Nvidia is super cheap if earnings hold; she would buy again as the stock bottoms before problems do.
  • Ed Zitron (bearish on NVIDIA): Nvidia is horrendously dependent on circular financing at a scale not yet known; more bad news ahead.
  • Steve Grasso (bearish on Bitcoin): Cyber-attack fears and no Clarity Act make Bitcoin a sell; he exited his Bitcoin ETFs.
  • Carter Braxton Worth (bullish on NVIDIA): Nvidia looks like a hold-your-nose buy; little downside after underperforming the chip index.

What was said, by company and theme

40 views from 6 speakers. Every quote is checked against the episode's transcript (how).

NVIDIA

Across the shows: 179 speakers in other episodes, 186 bullish and 188 bearish calls, past 30 days

Where everyone stands on NVIDIA

  • Tim Seymour · Seymour Asset ManagementUncertain

    Nvidia trades near 7x 2028 earnings; the selloff is retail capitulation, not a multiple problem.

    He notes the street's 2028 full-year estimate puts the stock at roughly seven times earnings, so this is not a multiple problem. He sees the drop as retail holders with big long-term gains throwing the stock out, which leaves an overhang and an uncertain path.

    “the multiple on the stock based upon where the street is on 2028 full year is somewhere around seven times here... this isn't a case of multiple... this was retail and people that have big long term gains in this stock throwing it out”at 5:04
  • Karen Finerman · Metropolitan Capital AdvisorsBullish

    Nvidia is super cheap if earnings hold; she would buy again as the stock bottoms before problems do.

    She holds the stock, rolling down her collars as the price fell, and says it is super cheap if the earnings are real. Even if the accounting probe trims earnings by a third, she still sees Nvidia as a critical company. She cites past cases such as BP and Equifax, where the stock bottomed before the problem did, and would buy some if she owned none.

    “the stock bottoms always before the problem bottoms. And so at some point, the stock bottoms. If I owned none, would I buy some next week? Yes, I would.”at 7:27
  • Steve Grasso · Grasso Global Inc.Uncertain

    Nvidia's interim CEO, who was there during the problems, shouldn't run the company.

    He argues the CFO who is now interim CEO has been at the company throughout the period under investigation. He says a company should not keep people around who were there when the situation was going bad. He still expects clarity on Nvidia to come, though the onion keeps peeling.

    “I don't believe she should be running the company for sort of what you just said, because she's been there while all of this was going on.”at 11:28
  • Ed Zitron · EZPRBearish

    Nvidia is horrendously dependent on circular financing at a scale not yet known; more bad news ahead.

    He ties the SEC investigation into Nvidia's accounting to a suspicion that Nvidia's business depends heavily on circular financing from AI customers it also funds. He argues there are many more paths to cover before the bad news is out, so the stock's drop is not finished and things get worse from here.

    “And there is something strange happening at Nvidia. And I think that company is horrendously dependent on circular financing to a scale we don't yet know.”at 15:47
  • Carter Braxton Worth · Worth Charting LLCBullish

    Nvidia looks like a hold-your-nose buy; little downside after underperforming the chip index.

    He says Nvidia has undercut its trend line only slightly and the pattern is damaged, but he has a hunch there is not much downside. Relative to the semiconductor index, which he sees as the weaker chart, Nvidia is so bad it is good, so holding one's nose and buying makes sense.

    “My hunch here is that there is not a lot of downside and that one is right to hold one's nose and buy this otherwise very damaged pattern.”at 34:47
  • Steve Grasso · Grasso Global Inc.Bullish

    Expects a near-term pop in Nvidia shares; use stops for downside protection.

    Grasso wants a rebound in tech and specifically in Nvidia after the recent selloff. He expects the bounce to come next week, when the market is quiet and traders are less likely to sell. He recommends using stops for downside protection, which shows the call is a short-term trade rather than a long-term view.

    “I'm looking for a pop in tech and I'm looking for a pop in Nvidia. Please use stops as downside protection.”at 47:08

Bitcoin

Across the shows: 32 speakers in other episodes, 29 bullish and 15 bearish calls, past 30 days

Where everyone stands on Bitcoin

  • Steve Grasso · Grasso Global Inc.Bearish

    Cyber-attack fears and no Clarity Act make Bitcoin a sell; he exited his Bitcoin ETFs.

    He ties reported cyber attacks and hacking fears to a reason to sell crypto, and says investors should use cold storage. Without clarity from the Clarity Act, holders become tourists rather than long-term holders. He sold his Grayscale mini Bitcoin and Ether ETFs at the start of last week.

    “So if there's been cyber attacks or perceived cyber attacks, I would see that as a reason to sell crypto. I also see it no clarity act.”at 30:14
  • Karen Finerman · Metropolitan Capital AdvisorsBearish

    Bitcoin is a risk-on momentum trade with no attractive value; the Clarity Act looks dead.

    She agrees with Grasso on the lack of clarity and says the Clarity Act seems dead, which is not good for crypto. Bitcoin is a very risk-on trade that moves like gold, with a different value proposition, so there is nothing attractive about it right now.

    “Clarity Act seems to be dead, so that's not good. It's a very risk on kind of thing... so there's nothing about it that's attractive right now.”at 31:00

Oracle

Across the shows: 34 speakers in other episodes, 10 bullish and 31 bearish calls, past 30 days

Where everyone stands on Oracle

  • Ed Zitron · EZPRBearish

    Oracle's 'fully capitalized' post reads like a company that isn't fine; it depends on OpenAI.

    Oracle posted publicly that it is fully capitalized to build its OpenAI data centers and that reports otherwise are not real. Zitron argues that a company issuing this kind of reassurance is usually not fine and does not have enough money. He adds that Oracle depends on OpenAI for its future, so the build-out financing looks fragile.

    “Oracle just put out a tweet saying, yeah, don't worry. If you hear any stories, they're not real... We are fully capitalized to do our open AI data centers.”at 15:23

OpenAI

Across the shows: 43 speakers in other episodes, 20 bullish and 35 bearish calls, past 30 days

Where everyone stands on OpenAI

  • Ed Zitron · EZPRBearish

    OpenAI's funding and compute demand look fragile; its loss would wipe out 40-50% of compute demand.

    OpenAI raised $11 billion at a $1.25 trillion private valuation, and he questions how it will fund itself and go public now. Citing Altman's comment that most AI compute demand comes from Anthropic and OpenAI, he argues that without OpenAI 40-50% of compute demand would evaporate, since there is no other large player. He doubts it can make it through the next six months.

    “How does OpenAI make it through the next six months? Is the question. And without OpenAI, we're looking at 40%, 50% of all compute demand evaporating.”at 17:40

Anthropic

Across the shows: 154 speakers in other episodes, 271 bullish and 136 bearish calls, past 30 days

Where everyone stands on Anthropic

  • Ed Zitron · EZPRBearish

    Anthropic's IPO marks the end of the AI trade; it was exit liquidity dumping venture capital on retail.

    He agrees the Anthropic IPO marks the end of the trade. The stock is trading only about 1.15-1.2x above the IPO price before lockups expire. He argues the company was sold as the next Google but was really a liquidity event that moved venture-backed value onto retail investors.

    “the Anthropic IPO is worrying because it was basically just exit liquidity. They sold this as the next Google, and really it's just another way to dump venture capital onto the unsuspecting retail investor”at 19:01

KraneShares CSI China Internet ETF

  • Tim Seymour · Seymour Asset ManagementBearish

    Selling KWeb on China tech regulatory headwinds; not ready to buy despite historically good entry.

    He says the price action in China tech has been driven by its relationship with the US government and regulatory headwinds, not domestic access to chips. He has been tax-harvesting by selling KWeb. The historical pattern suggests this may be the place to buy, but he is not ready to do so given the headwinds.

    “I guess I'm more concerned about the things that have been driving price action in these stocks and the valuations. Really, it's just been their relationship with the US government and regulatory headwinds from over here.”at 25:58

Johnson & Johnson

Across the shows: 2 speakers in other episodes, 2 bullish and 0 bearish calls, past 30 days

Where everyone stands on Johnson & Johnson

  • Tim Seymour · Seymour Asset ManagementNeutral

    Johnson & Johnson is expensive against its own history, but he would not sell it.

    Seymour acknowledges that Johnson & Johnson is expensive relative to its own valuation history. He still says he would not sell it, which implies he is holding it despite the premium. He sets it against Pfizer, which he sees as cheap by the same measure.

    “Pfizer is probably cheap to itself. J and J is expensive to itself, but I wouldn't sell that.”at 42:57

Pfizer

Across the shows: 3 speakers in other episodes, 2 bullish and 0 bearish calls, past 30 days

  • Tim Seymour · Seymour Asset ManagementBullish

    Pfizer looks cheap relative to its own history, so he would keep holding it.

    Seymour says Pfizer is cheap against its own valuation history, while Johnson & Johnson is expensive against its own. He holds both and says he would not sell Johnson & Johnson. He is presenting the two as opposite ends of the healthcare spectrum, with Pfizer's relative cheapness the reason it looks attractive to keep.

    “Pfizer is probably cheap to itself. J and J is expensive to itself, but I wouldn't sell that.”at 42:57

Alphabet

Across the shows: 77 speakers in other episodes, 67 bullish and 52 bearish calls, past 30 days

Where everyone stands on Alphabet

  • Tim Seymour · Seymour Asset ManagementBullish

    Alphabet is a buy: profitable and free-cash-flow generative, unlike AI-heavy names after the selloff.

    Seymour argues that the mega-cap tech names that were more profitable and generated more free cash flow, in a market less focused on AI, are the ones to revisit after the selloff. He includes Google (Alphabet) in his list of names he would be looking at. The argument is comparative and rests on cash generation relative to the AI-heavy names.

    “I would bring it back to the mega cap techs that seemingly were more profitable and more free cash flow generative in a world that was not so full of AI. And I am talking about Meta, Google, Amazon and Microsoft. So those would be names I would be looking at.”at 43:38

Meta Platforms

Across the shows: 61 speakers in other episodes, 54 bullish and 30 bearish calls, past 30 days

Where everyone stands on Meta Platforms

  • Tim Seymour · Seymour Asset ManagementBullish

    Meta is a buy: profitable and free-cash-flow generative, unlike AI-heavy names after the selloff.

    Seymour says investors should look back at the mega-cap tech names that were more profitable and generated more free cash flow in a market less focused on AI. He names Meta, Google, Amazon and Microsoft as the names he would be looking at as part of a buy list after the selloff. The reasoning is comparative: these firms have stronger cash generation than the AI-heavy names.

    “I would bring it back to the mega cap techs that seemingly were more profitable and more free cash flow generative in a world that was not so full of AI. And I am talking about Meta, Google, Amazon and Microsoft. So those would be names I would be looking at.”at 43:38

Amazon.com

Across the shows: 45 speakers in other episodes, 65 bullish and 8 bearish calls, past 30 days

Where everyone stands on Amazon.com

  • Tim Seymour · Seymour Asset ManagementBullish

    Amazon is a buy: profitable and free-cash-flow generative, unlike AI-heavy names after the selloff.

    Seymour argues that the mega-cap tech names that were more profitable and generated more free cash flow, in a market less focused on AI, are the ones to revisit after the selloff. He includes Amazon in his list of names he would be looking at. The argument is comparative and rests on cash generation relative to the AI-heavy names.

    “I would bring it back to the mega cap techs that seemingly were more profitable and more free cash flow generative in a world that was not so full of AI. And I am talking about Meta, Google, Amazon and Microsoft. So those would be names I would be looking at.”at 43:38

Microsoft

Across the shows: 47 speakers in other episodes, 50 bullish and 12 bearish calls, past 30 days

Where everyone stands on Microsoft

  • Tim Seymour · Seymour Asset ManagementBullish

    Microsoft is a buy: profitable and free-cash-flow generative, unlike AI-heavy names after the selloff.

    Seymour argues that the mega-cap tech names that were more profitable and generated more free cash flow, in a market less focused on AI, are the ones to revisit after the selloff. He includes Microsoft in his list of names he would be looking at. The argument is comparative and rests on cash generation relative to the AI-heavy names.

    “I would bring it back to the mega cap techs that seemingly were more profitable and more free cash flow generative in a world that was not so full of AI. And I am talking about Meta, Google, Amazon and Microsoft. So those would be names I would be looking at.”at 43:38

Invesco QQQ Trust (Nasdaq-100 ETF)

Across the shows: 3 speakers in other episodes, 1 bullish and 1 bearish calls, past 30 days

Where everyone stands on Invesco QQQ Trust (Nasdaq-100 ETF)

  • Karen Finerman · Metropolitan Capital AdvisorsBullish

    Expects a bounce early next week and plans to buy QQQ on that spike.

    Finerman expects a bounce in some holdings after the selloff, which makes her hedges less valuable, so she is taking them off. She plans to buy QQQ if there is a spike early next week, Monday or Tuesday. Her near-term call for a rebound is the basis for buying the Nasdaq-100 ETF on strength.

    “Hopefully Monday or Tuesday to buy triple Qs on a spike in the business.”at 46:53

US stock market outlook

Where everyone stands on US stock market outlook

  • Steve Grasso · Grasso Global Inc.

    Expects holiday seasonality to produce a sideways grind next week, then higher into year-end.

    He expects holiday-week seasonality to be strong, and he does not want to short a dull market. He sees the bottom grinding sideways Monday through Wednesday, and then the market moving higher into year-end.

    “next week holiday seasonality comes in real strong... I'm looking for the bottom to sort of grind sideways maybe Monday, Tuesday, Wednesday and then we start moving higher into year”at 11:43
  • Ed Zitron · EZPR

    Expects stocks to keep falling from here as an AI-spooked market faces more bad news.

    He says the market is already quite spooked about AI, and there are worrying signs, the Oracle post, the Altman demand comment and the SEC probe into Nvidia, which point to more bad news. He does not know how far the fall will go, but he expects declines to continue from here.

    “I hate to say it, but I think things are only gonna keep going down from here. I don't know by how much.”at 18:29
  • Carter Braxton Worth · Worth Charting LLC

    Expects the S&P 500 to fall to around 6,000 for a proper reset after excess.

    He says the ricochet is a small drawdown in the context of 10% plus declines. The next reference is about 16% from the peak, but the real destination is the January 2021 tops before the tariff selloff, which would take the S&P down to around 6,000. He sees that as a proper reset for a market with this much excess.

    “That would take us down to around 6,000. And I think that would be a proper reset for a market that's had this much excess.”at 33:20
  • Steve Grasso · Grasso Global Inc.

    Expects a near-term market bounce next week, with a dull holiday-travel market and fewer sell orders.

    Grasso expects a bounce next week. He says the market will be dull because many people will be traveling. People at their screens tend to hit sell more often than they would during a quiet vacation week. He does not need buying, just less selling. He expects the bounce to appear around Tuesday in the middle of the week, and he argues that the Anthropic-related portfolio sales pressured the same stocks already under pressure.

    “People, when they're sitting in front of their computers, they're hitting the sell button a lot more often... So I do believe that we're going to see a bounce... I think we'll probably see a bounce Tuesday, middle of the days that we have next week.”at 45:58

AI infrastructure & data centers

Where everyone stands on AI infrastructure & data centers

  • Steve Grasso · Grasso Global Inc.

    Hyperscaler capex is heading lower, not higher, which will be an ultimate tailwind for those stocks.

    He says the market has shown that hyperscalers get a tailwind once capex comes in, and he thinks capex is going lower rather than higher. He expects hyperscalers to come back in vogue once the spending concerns ease.

    “I think CapEx is going lower, not higher. So I think that's going be an ultimate tailwind.”at 9:46
  • Ed Zitron · EZPR

    Neoclouds are rate-sensitive and fully dependent on Nvidia, and their planned IPOs are doubtful.

    He says the neoclouds such as CoreWeave, Nebius and Iren are extremely sensitive to interest rates and are already offering to take customer prepayments. If those prepayments do not cover the build-out, they cannot fund their own operations. He notes they are fully dependent on Nvidia and doubts that the Nscale and Lambda IPOs will come to market.

    “the NeoClouds who are extremely interest rate sensitive, who are already saying, oh, we'll take customer prepayments.”at 16:25

US rates & the Fed

Where everyone stands on US rates & the Fed

  • Karen Finerman · Metropolitan Capital Advisors

    Commodity selloff and Waller's stance mean the Fed may only punt a 25bp move.

    She says the Fed wanted to hike but things have changed in the last two weeks. Waller, who is very aggressive, spoke this week, though other hawks such as Beth Hammack remain. Given the sharp drop in commodities such as copper, and bonds signaling something different, she thinks the Fed could just punt a 25 basis point move.

    “I agree the Fed wanted to hike. Things have changed in the last two weeks, Right? ... given what's happened to commodities... just look today, what's happened to copper”at 12:13
  • Tim Seymour · Seymour Asset Management

    The Fed risks coming in too strong and too late, like Volcker, ignoring copper and oil.

    He fears the Fed will tighten too much after being too slow, and that it did not listen to copper and oil prices on the way up, so it should not listen to them now. He says this Fed is trying to be different from prior Fed boards and reads like a Volcker-style Fed that cares about the perception of inflation becoming endemic, even with inflation five years above target.

    “I fear that we could have a case where the Fed is coming in way too strong, way too late and we weren't really listening to copper prices and oil prices on the way up.”at 13:03

Banks

Where everyone stands on Banks

  • Tim Seymour · Seymour Asset Management

    Banks are trading as if fighting for balance sheet on AI deals, signaling credit concern ahead.

    He says banks are trading as if there is more than the loss of an IPO. They competed against each other for balance sheet to finance parts of the AI trade. Even though many of those commitments may never become loans, he thinks there is credit-side concern, because the story is about deals that do not get done.

    “banks are also trading as if there is more than just a loss of an IPO. Banks are trading as if they were all fighting with each other to free up some balance sheet to help finance certain parts of the trade.”at 19:44
  • Karen Finerman · Metropolitan Capital Advisors

    Tough markets hurt bank dealmaking; debt capital markets and IPO fees look weak.

    She says it is hard to get deals and financing done. Equity capital markets volume is probably fine, but debt capital markets will be difficult. IPO paydays carry a much lower multiple than the bread-and-butter business, and a tough market has not been good for banks.

    “it's hard to also get deals done, it's hard to get financing done... debt capital markets, that'll be difficult.”at 20:30

Gold & precious metals

Where everyone stands on Gold & precious metals

  • Steve Grasso · Grasso Global Inc.

    Gold should rally now as growth weakens and the copper market turns oversupplied.

    He argues copper's shift to oversupply reflects weakening growth, and oil is collapsing as the war premium leaves. In that setting he says this is when gold should be rallying, even without a hot war on the ground.

    “So when you look at gold, this is the time where gold should be rallying.”at 21:55
  • Tim Seymour · Seymour Asset Management

    Gold is a buy, not a sell: the selloff is funding-driven and central banks may step in.

    He says gold is no longer a safety trade and is now a funding trade, with profits sold to meet margin calls. Positioning was extremely light and much of the move is futures-driven, so the drop is not a fundamental signal. With a strong dollar, a hawkish Fed and risk-off conditions, a Fed that missed something makes gold a reason to buy. Physical demand should be invigorated at lower prices, and he has been long gold.

    “I actually think central banks will begin. They don't need to jump into volatility here. The physical gold market actually gets, invigorated by lower prices... this is the time to buy gold, not sell it.”at 22:54

Pharma & biotech

Where everyone stands on Pharma & biotech

  • Jared Holz · Mizuho Securities

    Healthcare isn't a buy yet; large-cap pharma trades 15-20x and the sector shows no discount to history.

    Healthcare has been hit this week, but Holz says it is not yet a buying opportunity. The group has had only one bad week in the past eight or ten. Large-cap pharma trades at 15-20 times earnings, life science tools trade in the mid-20s near their highs, and managed care is in line with its history. He says they are not trading at any discount to their historical averages, unlike the consumer staples group, which still trades well below its ten-year average.

    “I don't think so yet. I mean, we've pretty much had one lousy week over the past eight or ten. ... Large cap pharma's trading 15 to 20 times, depending. ... I wouldn't say they're trading at any discount for sure.”at 38:30
  • Jared Holz · Mizuho Securities

    Beaten-down quality biotech names could recover through mean reversion as the buy side returns.

    Holz sees the biggest path to a biotech recovery as mean reversion. Some high-quality commercial names have been hit hardest, and Insmed was one of them until a takeout rumor a couple of days ago. Many high-quality companies have been left alone by the buy side because there is no near-term catalyst. He also notes that biotech has done far worse than the index if you exclude a few one-off names, and that small and mid-cap names have been badly hit.

    “I think part of it would be pure mean reversion. Some of the higher quality commercial names that have been hit the hardest, Insmed was one of them up until a couple days ago with this takeout rumor.”at 40:44

Copper & industrial metals

Where everyone stands on Copper & industrial metals

  • Steve Grasso · Grasso Global Inc.

    Copper will sell off as growth weakens, shifting the market from undersupply to oversupply.

    He calls copper the heartbeat for growth, and the data center trade absorbed a lot of it. Copper was in an undersupplied market, but if growth cascades lower, copper sells off and the market now sees oversupply as growth weakens.

    “If you're thinking that growth is going to be cascading lower, then copper is going to sell off. We were in an under supplied copper market. Now we think we're oversupplied because growth is actually weakening.”at 21:40

US–China relations

Where everyone stands on US–China relations

  • Steve Grasso · Grasso Global Inc.

    China tech trades on policy, not profits; anti-China momentum and the January truce expiry loom.

    He says the new Congress seats January 3 with bipartisan anti-China momentum, and the trade truce ends January 10. He argues China tech stocks cannot be bought because they depend more on policy than profits, so these events weigh on them.

    “January 10, you get the truce ending, the trade truce ending... these stocks say that you can't buy it because it's more dependent on policy, not profits.”at 28:40

Consumer & retail

Where everyone stands on Consumer & retail

  • Carter Braxton Worth · Worth Charting LLC

    The staples bounce looks overdone; he would fade the move as relative performance hits a downtrend.

    He says staples are loved and the chart suggests the bounce is overdone. On a relative basis, staples divided by the market, the ricochet runs into a well-defined downtrend line. He reads it as rotation that has already gone too far, so he would fade the move in staples.

    “So this ricochet leaves you up against a well defined downtrend line. Meaning this is money flow, it's rotation, but it's already gone too far... So I would fade the move in staples.”at 33:48

AI chips & semiconductors

Where everyone stands on AI chips & semiconductors

  • Carter Braxton Worth · Worth Charting LLC

    The chip index should find buyers near a 45% drawdown from its peak.

    He notes the SOX doubled from March 30 to June 22 and has not given all of that back. He points to a level that would be about a 45% selloff from the peak as where buyers will come in earnest, and he thinks the index is getting there.

    “that would be from the peak of 45% sell off. We're getting there. And I think that's where we'll find sort of buyers in earnest.”at 34:32

Market sentiment, positioning & volatility

Where everyone stands on Market sentiment, positioning & volatility

  • Karen Finerman · Metropolitan Capital Advisors

    VIX near 40 is high; the setup looks like a coiled spring ready to bounce.

    She reviews recent VIX spikes: about 80 in COVID, 40 in the yen carry unwind and 50 on Liberation Day. The VIX touched 40 today, which is getting pretty high. She sees the setup as a coiled spring, implying a possible rebound from the stress.

    “this is really setting up to be, coil spring, I think... so here it touched 40 today. That's getting pretty high.”at 35:28

IPOs, M&A & deal activity

Where everyone stands on IPOs, M&A & deal activity

  • Jared Holz · Mizuho Securities

    The pharma M&A cycle should pick up into year-end and next year after a slow pause.

    Holz expects dealmaking to pick up sharply into year-end and next year. The first half of this year was very active, and the recent slowdown is a pause, not a trend change. Large-cap pharma needs acquisitions to keep revenue from falling below zero growth, and biotech offers the consistent revenue growth they need. He cites hundreds of possible targets, and says medical devices have also seen strategic and private equity deals.

    “And then obviously, I think the m and a cycle is gonna pick up dramatically into year end into next year because the first half of this year was so profound. There's been a little bit of a pause.”at 41:09

Oil & fuels

Where everyone stands on Oil & fuels

  • Karen Finerman · Metropolitan Capital Advisors

    Trim energy after its great run, but keep it at market weight or slightly overweight.

    Finerman, who describes herself as an energy bull, says energy has had a great run and she is trimming her overweight. She says commodities have already moved, and the rally may have run its course. She still wants energy at market weight and possibly a little overweight, so she is reducing exposure rather than exiting it.

    “I think you're trimming some energy here. It's been a great run. And I think along with commodities, which have already you could argue that ship has already sailed, I still think you want to be a market weight energy and maybe even a little bit overweight.”at 44:13

Across the shows

What other episodes Chorus covered said about the same companies in the 30 days up to this one.

  • NVIDIA179 speakers · 186 bullish, 188 bearish calls
  • Anthropic154 speakers · 271 bullish, 136 bearish calls
  • Alphabet77 speakers · 67 bullish, 52 bearish calls
  • Meta Platforms61 speakers · 54 bullish, 30 bearish calls
  • Microsoft47 speakers · 50 bullish, 12 bearish calls
  • Amazon.com45 speakers · 65 bullish, 8 bearish calls
  • OpenAI43 speakers · 20 bullish, 35 bearish calls
  • Oracle34 speakers · 10 bullish, 31 bearish calls
  • Bitcoin32 speakers · 29 bullish, 15 bearish calls
  • Invesco QQQ Trust (Nasdaq-100 ETF)3 speakers · 1 bullish, 1 bearish calls
  • Pfizer3 speakers · 2 bullish, 0 bearish calls
  • Johnson & Johnson2 speakers · 2 bullish, 0 bearish calls

Ask your AI who they are and what they said

Topics

  • Anthropic IPO
  • China tech regulatory headwinds
  • Clarity Act
  • Fed hike odds
  • Fed policy error risk
  • Johnson & Johnson valuation
  • Nvidia accounting and earnings risk
  • Nvidia chart technicals
  • Nvidia leadership
  • Nvidia valuation after selloff
  • OpenAI funding and compute demand
  • Pfizer valuation
  • VIX and volatility spikes
  • bank credit exposure to AI financing
  • biotech mean reversion
  • circular financing
  • consumer staples rotation
  • copper demand
  • data center financing
  • energy sector positioning
  • gold price direction
  • healthcare sector valuation
  • hyperscaler capex
  • index downside targets
  • investment banking fees
  • mega-cap tech free cash flow
  • momentum and regulatory clarity
  • near-term bounce
  • near-term market direction
  • near-term rebound
  • neocloud financing
  • pharma M&A
  • semiconductor index support
  • trade truce expiry

More from CNBC Fast Money

All CNBC Fast Money episodes

Ask your AI about this episode

Chorus gives Claude, ChatGPT and other assistants every view from this episode and every other show Chorus follows. Ask who agrees, who changed their mind, and what else was said about the same companies.

A weekly email with the calls that mattered from the most important voices in investing. Unsubscribe any time. Privacy Policy

Chorus reports what speakers said. It isn't investment advice. How Chorus works · About Chorus